Wordt geladen...
Challenges assessing clinical endpoints in early Huntington disease
The primary aim of this study was to evaluate the current accepted standard clinical endpoint for the earliest-studied HD participants likely to be recruited into clinical trials. Since the advent of genetic testing for HD, it is possible to identify gene carriers prior to the diagnosis of disease,...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2978744/ https://ncbi.nlm.nih.gov/pubmed/20623772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.23337 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|